5Hawkins P N,Pepys M B. Imaging amyloidosis with radiolabelled SAP[J].European Journal of Nuclear Medicine,1995,(07):595-599.doi:10.1007/BF01254559.
6Mohr A,Miehlke S,Klauck S. Hepatomegaly and cholestasis as primary clinical manifestations of an AL-kappa amyloidosis[J].European Journal of Gastroenterology and Hepatology,1999,(08):921-925.doi:10.1097/00042737-199908000-00020.
8Kisilevsky R. Anti-amyloid drugs:potential in the treatment of diseases associated with aging[J].Drugs and Aging,1996,(02):75-83.doi:10.2165/00002512-199608020-00001.
3Hanley JP, MacLean FR, Evans JL, et al. Hemorrhagic lymphadenopathy as a presenting feature of primary al amyloidosis. Pathology, 2000,32(1) :21 - 23.
4Park MA, Mueller PS, Kyle RA, et al. Primary (AL) hepatic amyloidosis: clinical features and natural histzay in 98 patients. Mediclne (Baltimore) ,2003,82(5) :291 - 298.
5Oshima K, Kanda Y, Nannya Y, et al. Clinical and pathologic findings in 52 consecutively autopsiod cases with multiple myeloma. Am J Hematol,2001,67(1) : 1 - 5.
6Usui M, Matsuda S, Suzuki H, et al. Gastric amyloidosis with maseive bleeding requiring emergency surgery. J Gastroenterol,2000,35(12) :924 -928.
